Kings Biotech Private Limited
About Kings Biotech Private Limited
Data last updated:
Kings Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 09 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC277651. Its GSTIN is 06AAFCK7740R1ZV (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Satya Narain Deswal and Bimla Devi.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Land Mark Near Community Centre Akber Pur Village Akbarpur Majra, New Delhi, Delhi, India – 110036.
As per the financials filed for FY 2022, the company reported a revenue of ₹19.77 Lakh, a growth of 33% compared to the previous year. For the same year it recorded a net loss of ₹1.2 Lakh (net margin -6.1%) and EBITDA of -₹1.2 Lakh (EBITDA margin -6.1%). Revenue has declined at a compounded annual rate (CAGR) of 92% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kings Biotech Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressLand Mark Near Community Centre Akber Pur Village Akbarpur Majra, New Delhi, Delhi, India – 110036
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Kings Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kings Biotech is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Kings Biotech Private Limited, buy the company report.
Financials of Kings Biotech Private Limited
FY 2022 filings availableKings Biotech Private Limited reported revenue of ₹19.77 Lakh (up 33% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 33% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA fell 201% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.1% | ||||
| Net Profit Margin | -6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kings Biotech Private Limited, buy the company report.
Board of directors of Kings Biotech Private Limited
Kings Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bimla Devi | Additional Director | 07 Jan 2019 | 7 Years 9 Months | Current |
| Satya Narain Deswal | Director | 09 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Kings Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dream Barter Private Limited | ₹19.78 Lakh (FY 2025) | 12.0% | Kolkata, West Bengal, India | |||
| Sonawala Integrated Circuit Industries Private Limited | ₹19.77 Lakh (FY 2023) | 11.0% | Bharuch, Gujarat, India | |||
| Skola Toys Private Limited | ₹19.77 Lakh (FY 2024) | 20.0% | Bangalore, Karnataka, India | |||
| Imperiumplus Solutions Private Limited | ₹19.77 Lakh (FY 2018) | -11.0% | Mumbai, Maharashtra, India | |||
| BRR Business Solutions Private Limited | ₹19.77 Lakh (FY 2022) | -6.0% | Gurugram, Haryana, India | |||
| Kings Biotech Private Limitedthis company | ₹19.77 Lakh (FY 2022) | -₹1.2 Lakh | -6.1% | 33.0% | New Delhi, Delhi, India | |
| Chartered Motors Private Limited | ₹19.76 Lakh (FY 2025) | -80.0% | Ahmedabad, Gujarat, India | |||
| Drishtideep Diagnostics & Research Private Limited | ₹19.76 Lakh (FY 2018) | 30.0% | Kolkata, West Bengal, India | |||
| Ramkrishna Nagar Farmer Producer Company Limited | ₹19.76 Lakh (FY 2024) | 138.0% | Karimganj, Assam, India | |||
| Goodshine Infraprojects Private Limited | ₹19.76 Lakh (FY 2024) | -51.0% | Kolkata, West Bengal, India | |||
| Charrlie Creation Private Limited | ₹19.75 Lakh (FY 2025) | 37.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Kings Biotech Private Limited, buy the company report.
Auditor
Kings Biotech Private Limited is audited by PRASHANT ARYA AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRASHANT ARYA AND ASSOCIATES | FY 2017 | 022557N |
Shareholding
The shareholding of Kings Biotech Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kings Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kings Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kings Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kings Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCK7740R1ZV | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kings Biotech Private Limited, buy the company report.
Recent activity
Kings Biotech Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Ritu ceased to be Additional Director on 09 Jan 2019.
Frequently asked questions
Kings Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in retail trading, within the trading industry. It was incorporated on 09 March 2015 (11+ years old) and is registered under CIN U24100DL2015PTC277651.
Kings Biotech has 2 current directors:
- Bimla Devi - Additional Director
- Satya Narain Deswal - Director
The latest financial statements of Kings Biotech on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Kings Biotech is 06AAFCK7740R1ZV, registered in Haryana.
The CIN (Corporate Identification Number) of Kings Biotech is U24100DL2015PTC277651. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kings Biotech was incorporated on 09 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Kings Biotech by revenue are Dream Barter Private Limited, Sonawala Integrated Circuit Industries Private Limited, Skola Toys Private Limited, Imperiumplus Solutions Private Limited, BRR Business Solutions Private Limited and 5 more, all in the same principal business activity (retail trading).
Ritu ceased to be Additional Director on 09 Jan 2019. Bimla Devi was appointed as Additional Director on 07 Jan 2019. Mukesh Kumar ceased to be Director on 28 Jul 2016. Kings Biotech has 4 board changes on record in total.
The registered office of Kings Biotech is at Land Mark Near Community Centre Akber Pur Village Akbarpur Majra, New Delhi, Delhi, India – 110036.
Kings Biotech operates in the trading industry, in the retail trading segment.
The compliance status of Kings Biotech is compliant as of 01 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
